Home › Amblyopia › NCT04310241
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
Oculomotor Disorders: Experimental and Clinical Study
Who can join
6 Months – 90 Years · All sexes
Full eligibility criteria
Inclusion Criteria: * History of amblyopia or presence of amblyogenic risk factors. Exclusion Criteria: * History of neurologic disorders
About the study
Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated patients have residual visual function deficits. The purpose of the current study is to quantify various visual functions in amblyopic and strabismic participants at baseline, during and at the completion of treatment.
What is being tested
- Patching therapy, Glasses (behavioral)
Sponsor: The Cleveland Clinic · Participants: 150 · Started: Feb 21, 2020
Contact the study team
- Kimberly Baynes, MSN · Phone: 216-444-2566
Official record on ClinicalTrials.gov — NCT04310241
Locations in the U.S.
| Ohio | Cleveland Clinic, Cleveland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.